Trends, Entrants, and Developments (TEDs) Impacting Access: Models, Measures, and Practices Impacting Healthcare Delivery and Quality

I’m Elizabeth Oyekan, PharmD, FCSHP, CPHQ, Vice President, Access Experience Team, and editor of the All Access Newsletter. In the midst of the pandemic uncertainties, organizations are continuing their quest toward a value-based healthcare ecosystem with an emphasis on alternative payment models (APMs), quality improvements, and innovations in pursuit of the Quintuple Aim—better patient outcomes, smarter spending, improved patient access, and addressing health equities, while supporting the workforce. In this edition of the All Access Newsletter, we have asked our key expert ex-payers to provide insights into some of these evolving practices, measures, innovations, and stakeholders involved in the quest for healthcare transformation.

• Dominic Galante takes us into the world of the Quality Payment Program (QPP) by reintroducing us to the purpose behind the shift from volume to value, the laws that have catalyzed this shift, and the resultant APMs.
• Maureen Hennessey provides a great overview of the changes to the 2022 QPP proposed quality measures and improvement activities, suggested landscape analysis, and customer partnership opportunities for pharmaceutical manufacturers in the quality and clinical improvement areas.
• Joe Honcz takes us into the world of digital therapeutics (DTx) and how they differ from wearables. With the increase in demand and use, Joe discusses challenges around coverage and access.
• As stakeholders across the healthcare system look to value-based care models to improve healthcare outcomes and quality while decreasing overall costs, Erin Lopata highlights 5 significant trends that manufacturers can partner with payers and health systems on in their quest for value-based care.
• Finally, Jorge Font takes us into the world of employers and the various roles in promoting and improving the quality of care. Jorge gives some insights on how life science organizations can engage and support employers to raise their understanding of the value of certain therapeutic approaches aligned with the employers’ quest to improve quality and care for consumers.

We believe you will find these current and evolving payer practices around the adoption of new models, measures, and practices impacting healthcare and their impact on access insightful as you navigate the payer landscape. As always, please feel free to drop me a note and let me know if you have a topic suggestion for the payer team to address, and we’ll do our best to cover it in a future edition.

Best regards,

Elizabeth Oyekan
PharmD, FCSHP, CPHQ
Vice President,
Access Experience Team
EMAIL ELIZABETH